G3O Stock Overview
Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
S.M.A.I.O S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.13 |
| 52 Week High | €5.34 |
| 52 Week Low | €3.12 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -41.12% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| G3O | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.2% |
| 1Y | -41.1% | -6.8% | 8.5% |
Return vs Industry: G3O underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: G3O underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| G3O volatility | |
|---|---|
| G3O Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: G3O has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine G3O's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 30 | Philippe Roussouly | smaio.com |
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. The company was incorporated in 2009 and is based in Saint-Priest, France.
S.M.A.I.O S.A. Fundamentals Summary
| G3O fundamental statistics | |
|---|---|
| Market cap | €17.78m |
| Earnings (TTM) | €3.88m |
| Revenue (TTM) | €3.22m |
4.6x
P/E Ratio5.5x
P/S RatioIs G3O overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| G3O income statement (TTM) | |
|---|---|
| Revenue | €3.22m |
| Cost of Revenue | €2.39m |
| Gross Profit | €825.71k |
| Other Expenses | -€3.05m |
| Earnings | €3.88m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 18, 2023
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 25.66% |
| Net Profit Margin | 120.52% |
| Debt/Equity Ratio | 3.0% |
How did G3O perform over the long term?
See historical performance and comparison